BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Abdenoflast readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Abdenoflast\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06836232-11229@assetmemo.bio
DTSTAMP:20261121T004050Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Abdenoflast: Phase 2 readout est. (NCT06836232)
DESCRIPTION:Abdenoflast\, phase 2\, Recurrent Pericarditis.\nStudy: An Open
 -Label Pilot Study of VTX2735 in Recurrent Pericarditis\nEstimated primary
  completion: October 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/abdenoflast#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT06836232
URL:https://assetmemo.bio/drug/abdenoflast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
